Bank Julius Baer & Co. Ltd, Zurich Regeneron Pharmaceuticals, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 107,989 shares of REGN stock, worth $77.2 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

107,989

Previous 112,948 4.39%

Holding current value

$77.2 Million

Previous $119 Million 4.37%

% of portfolio

0.44%

Previous 0.5%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $5.08 Million - $5.96 Million	-4,959 Reduced 4.39%	107,989 $114 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $4.36 Million - $5.28 Million	-4,933 Reduced 4.18%	112,948 $119 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $26 Million - $28.6 Million	28,826 Added 32.37%	117,881 $113 Million
Q4 2023 May 16, 2024	SELL	$775.18 - $881.7 $89.7 Million - $102 Million	-115,665 Reduced 98.12%	2,216 $1.95 Million
Q4 2023 May 16, 2024	BUY	$775.18 - $881.7 $67.3 Million - $76.6 Million	86,839 Added 3918.73%	89,055 $78.2 Million
Q4 2023 Feb 02, 2024	BUY	$775.18 - $881.7 $3.84 Million - $4.37 Million	4,954 Added 5.89%	89,055 $78.2 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $6.2 Million - $7.55 Million	8,947 Added 11.9%	84,101 $69.2 Million
Q2 2023 Jul 24, 2023	BUY	$700.03 - $830.35 $52.6 Million - $62.4 Million	75,154 New	75,154 $54 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $4.93 Million - $5.99 Million	7,246 Added 9.77%	81,434 $66.9 Million
Q4 2022 Jan 24, 2023	SELL	$705.89 - $766.39 $19.4 Million - $21.1 Million	-27,470 Reduced 27.02%	74,188 $53.5 Million
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $237,049 - $299,144	413 Added 0.41%	101,658 $70 Million
Q2 2022 Jul 22, 2022	BUY	$548.35 - $738.84 $54.6 Million - $73.5 Million	99,535 Added 5820.76%	101,245 $59.8 Million
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $704,026 - $826,242	1,183 Added 224.48%	1,710 $1.19 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $4,347 - $5,367	-8 Reduced 1.5%	527 $333,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $167,616 - $198,840	-292 Reduced 35.31%	535 $324,000
Q2 2021 Jul 23, 2021	BUY	$472.8 - $558.54 $36,405 - $43,007	77 Added 10.27%	827 $462,000
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $49,587 - $60,850	-111 Reduced 12.89%	750 $355,000
Q4 2020 Feb 24, 2021	SELL	$478.3 - $607.98 $874,332 - $1.11 Million	-1,828 Reduced 67.98%	861 $416,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $945,120 - $1.2 Million	1,976 Added 277.14%	2,689 $416,000
Q3 2020 Nov 10, 2020	SELL	$544.75 - $658.21 $525,683 - $635,172	-965 Reduced 57.51%	713 $399,000
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $827,790 - $1.08 Million	1,678 New	1,678 $1.05 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Regeneron Pharmaceuticals, Inc. Transaction History